nach oben

Current Psychiatry Reports

Erschienen in:

01.08.2020 | Anxiety Disorders (A Pelissolo, Section Editor)

The Role of Anxiety in Smoking Onset, Severity, and Cessation-Related Outcomes: a Review of Recent Literature

verfasst von: Lorra Garey, Hannah Olofsson, Tatyana Garza, Justin M. Shepherd, Tanya Smit, Michael J. Zvolensky

Erschienen in: Current Psychiatry Reports | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Anxiety is one of the most common mental health conditions globally and co-occurs with smoking at a markedly high rate. The present review offers a narrative overview of the most recent research on the role of anxiety in smoking onset, maintenance, and cessation-related outcomes. Additionally, given the rise in electronic cigarette use, we review the emerging literature on the influence of anxiety on e-cigarette use.

Recent Findings

Evidence across studies varied as to the role of anxiety or anxiety symptoms in smoking behavior. The most consistent findings suggested that those with anxiety are more likely to be a smoker, supporting a high rate of co-occurrence across these conditions. Less consistent evidence was observed for the association between anxiety and onset, indicators of severity, and cessation outcomes.

Summary

Although there is robust evidence for an association between smoking and anxiety, there were considerable discrepancies for the precise role of anxiety in smoking onset, severity, and cessation outcomes. Future work utilizing more sophisticated methodologies is needed to identify causal relations as well as putative moderators and mediators of the anxiety–smoking relation.

Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169–84.PubMedPubMedCentral

National Institute of Mental Health NIMH Any anxiety disorder. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder.shtml. Accessed 18 Apr 2020.

Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17:327–35.PubMedPubMedCentral

Moylan S, Jacka FN, Pasco JA, Berk M. Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med. 2012;10:123.PubMedPubMedCentral

Lawrence D, Considine J, Mitrou F, Zubrick SR. Anxiety disorders and cigarette smoking: results from the Australian Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2010;44:520–7.PubMed

Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010;78:13–23.PubMedPubMedCentral

Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285.PubMedPubMedCentral

Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606–10.PubMed

Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:1107–15.PubMed

10.

Williams JM, Steinberg ML, Griffiths KG, Cooperman N. Smokers with behavioral health comorbidity should be designated a tobacco use disparity group. Am J Public Health. 2013;103:1549–55.PubMedPubMedCentral

11.

Morissette SB, Tull MT, Gulliver SB, Kamholz BW, Zimering RT. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull. 2007;133:245–72.PubMed

12.

Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111:33–51.PubMed

13.

Pomerleau OF, Turk DC, Fertig JB. The effects of cigarette smoking on pain and anxiety. Addict Behav. 1984;9:265–71.PubMed

14.

Morrell HER, Cohen LM. Cigarette smoking, anxiety, and depression. J Psychopathol Behav Assess. 2006;28:281–95.

15.

Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome, and response to treatment. Addiction. 2011;106:418–27.PubMed

16.

Watson NL, VanderVeen JW, Cohen LM, DeMarree KG, Morrell HER. Examining the interrelationships between social anxiety, smoking to cope, and cigarette craving. Addict Behav. 2012;37:986–9.PubMed

17.

Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry. 1992;149:464–9.PubMed

18.

• Tidey JW, Miller ME (2015) Smoking cessation and reduction in people with chronic mental illness. BMJ. https://doi.org/10.1136/bmj.h4065. This review summarizes findings on the effects and mechanisms of smoking cessation treatment on psychiatric smokers. It found strong empirical evidence for an association between anxiety and smoking onset, behavior and treatment outcomes. It also discusses vulnerability factors, which may underlie the anxiety/smoking co-occurrence.

19.

Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health. 1998;88:1518–22.PubMedPubMedCentral

20.

•• Fluharty M, Taylor AE, Grabski M, Munafò MR. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res. 2017;19:3–13. This systematic review examined the relation between anxiety and smoking in longitudinal studies and found mixed results for the bidirectionality of their association. PubMed

21.

•• Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull. 2015;141:176–212. This is the first review to introduce an integrative theoretical framework to identify factors influencing the associations between anxiety and smoking trajectories. PubMed

22.

Centers for Disease Control and Prevention (2019) Surgeon general’s advisory on e-cigarette use among youth | Smoking & Tobacco Use | CDC. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/surgeon-general-advisory/index.html. Accessed 16 Apr 2020.

23.

Cummins SE, Zhu S-H, Tedeschi GJ, Gamst AC, Myers MG. Use of e-cigarettes by individuals with mental health conditions. Tob Control. 2014;23:iii48–53.PubMed

24.

Kellam SG, Anthony JC. Targeting early antecedents to prevent tobacco smoking: findings from an epidemiologically based randomized field trial. Am J Public Health. 1998;88:1490–5.PubMedPubMedCentral

25.

Spindle TR, Hiler MM, Cooke ME, Eissenberg T, Kendler KS, Dick DM. Electronic cigarette use and uptake of cigarette smoking: a longitudinal examination of U.S. college students. Addict Behav. 2017;67:66–72.PubMed

26.

•• Parker MA, Sigmon SC, Villanti AC. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses. Addict Behav. 2019;99:106112. This article used epidemiological data to look at comorbidity rates of psychiatric disorders, cigarette smoking, and other drug use. They found that individuals with anxiety symptoms as well as current or lifetime history of anxiety disorder were more likely to be smokers. PubMedPubMedCentral

27.

Stanton CA, Keith DR, Gaalema DE, Bunn JY, Doogan NJ, Redner R, et al. Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005–2013. Prev Med. 2016;92:160–8.PubMedPubMedCentral

28.

Ellis EM, Orom H, Giovino GA, Kiviniemi MT. Relations between negative affect and health behaviors by race/ethnicity: differential effects for symptoms of depression and anxiety. Health Psychol. 2015;34:966–9.PubMed

29.

•• Bierhoff J, Haardörfer R, Windle M, Berg CJ. Psychological risk factors for alcohol, cannabis, and various tobacco use among young adults: a longitudinal analysis. Subst Use Misuse. 2019;54:1365–75. This longitudinal study examined the use of alcohol, cannabis, and various tobacco products in relation to externalizing and internalizing factors. It found that anxiety symptoms are predictive of cigarette use and severity. The same relation was not found for anxiety symptoms and e-cigarette use. PubMedPubMedCentral

30.

Leventhal AM, Strong DR, Sussman S, Kirkpatrick MG, Unger JB, Barrington-Trimis JL, et al. Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016;73:71–8.PubMed

31.

Tong L, Shi H-J, Zhang Z, Yuan Y, Xia Z-J, Jiang X-X, et al. Mediating effect of anxiety and depression on the relationship between attention-deficit/hyperactivity disorder symptoms and smoking/drinking. Sci Rep. 2016;6. https://doi.org/10.1038/srep21609.

32.

Keten HS, Ersoy O, Satan Y, Olmez S, Ucer H, Sahin M, et al. Determination of the relationship between cigarette and smokeless tobacco (Maras powder) use and depression/anxiety. Acta Medica Mediterranea. 2015:899–905.

33.

•• Richardson S, McNeill A, Brose LS. Smoking and quitting behaviours by mental health conditions in Great Britain (1993–2014). Addict Behav. 2019;90:14–9. This article used data from the nationally representative Adult Psychiatric Morbidity Survey. It examined trends in smoking prevalence in Great Britain among those with and without mental health conditions. Results showed that both phobia and generalized anxiety disorder related to dependence, greater desire to quit, and that individuals with generalized anxiety experienced more difficulties associated with quitting. Yet, neither generalized anxiety disorder nor phobia was shown to relate to quit success. PubMedPubMedCentral

34.

Matcham F, Carroll A, Chung N, Crawford V, Galloway J, Hames A, et al. Smoking and common mental disorders in patients with chronic conditions: an analysis of data collected via a web-based screening system. Gen Hosp Psychiatry. 2017;45:12–8.PubMed

35.

Jamal M, Van der Does W, Penninx BWJH. Effect of variation in BDNF Val66Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders. Drug Alcohol Depend. 2015;148:150–7.PubMed

36.

Sawchuk CN, Roy-Byrne P, Noonan C, Bogart A, Goldberg J, Manson SM, et al. The association of panic disorder, posttraumatic stress disorder, and major depression with smoking in American Indians. Nicotine Tob Res. 2016;18:259–66.PubMed

37.

• Lopez AA, Toblin RL, Riviere LA, Lee JD, Adler AB. Correlates of current and heavy smoking among US soldiers returning from combat. Exp Clin Psychopharmacol. 2018;26:215–22. This large cross-sectional study on veterans assessed smoking behavior and co-occurrence rates of several variables including combat exposures and anxiety. Results from covariate adjusted models indicated that anxiety was not associated with smoking status and severity. PubMed

38.

• Berg CJ, Haardörfer R, Payne JB, Getachew B, Vu M, Guttentag A, et al. Ecological momentary assessment of various tobacco product use among young adults. Addict Behav. 2019;92:38–46. This ecological momentary assessment study that examined timing, tobacco cravings, affect, social context, and other substance use in relation to use of cigarettes and other nicotine delivery systems. They found that higher levels of anxiety are a predictor for cigarette use; this association was not present for e-cigarette use. PubMed

39.

Trujillo MA, Khoddam R, Greenberg JB, Dyal SR, Ameringer KJ, Zvolensky MJ, et al. Distress tolerance as a correlate of tobacco dependence and motivation: incremental relations over and above anxiety and depressive symptoms. Behav Med. 2017;43:120–8.PubMed

40.

Zvolensky MJ, Bakhshaie J, Norton PJ, Smits JAJ, Buckner JD, Garey L, et al. Visceral sensitivity, anxiety, and smoking among treatment-seeking smokers. Addict Behav. 2017;75:1–6.PubMed

41.

Chase T, Teng EJ, Schmidt NB, Zvolensky MJ. Emotion regulation difficulties in relation to anxiety, depression, and functional impairment among treatment-seeking smokers. J Nerv Ment Dis. 2018;206:614–20.PubMed

42.

Ghali H, Rejeb OB, Fredj SB, Khéfacha S, Dhidah L, Rejeb MB, et al. Smoking dependence and anxio-depressive disorders in Tunisian smokers attending the smoking cessation clinic in a university hospital. J Egypt Public Health Assoc. 2019;94:9.PubMedPubMedCentral

43.

• Watson NL, Heffner JL, Mull KE, McClure JB, Bricker JB. Comparing treatment acceptability and 12-month cessation rates in response to web-based smoking interventions among smokers who do and do not screen positive for affective disorders: Secondary Analysis. J Med Internet Res. 2019. https://doi.org/10.2196/13500. This longitudinal study compared web-based treatment acceptability and cessation outcomes between smokers with and without affective disorders. Findings showed lower cessation rates across smokers with panic disorder and generalized anxiety disorder.

44.

Foster DW, Langdon KJ, Schmidt NB, Zvolensky MJ. Smoking processes, panic, and depressive symptoms among treatment-seeking smokers. Subst Use Misuse. 2015;50:394–402.PubMed

45.

• Tulloch HE, Pipe AL, Clyde MJ, Reid RD, Els C. The quit experience and concerns of smokers with psychiatric illness. Am J Prev Med. 2016;50:709–18, This cross-sectional study examined quit experience and concerns of smokers with psychiatric illness in comparison with those of smokers without psychiatric illness. Results showed that smokers with anxiety are particularly vulnerable to relapse at times of stress and negative affect; as they worry they may not be able to cope with stress without cigarettes. PubMed

46.

Yang M-J, Zvolensky MJ, Leyro TM. The indirect effect of panic disorder on smoking cognitions via difficulties in emotion regulation. Addict Behav. 2017;72:126–32.PubMedPubMedCentral

47.

Farris SG, Allan NP, Morales PC, Schmidt NB, Zvolensky MJ. Does successful smoking cessation reduce anxious arousal among treatment-seeking smokers? J Anxiety Disord. 2015;36:92–8.PubMedPubMedCentral

48.

Watson NL, DeMarree KG, Cohen LM. Cigarette craving and stressful social interactions: the roles of state and trait social anxiety and smoking to cope. Drug Alcohol Depend. 2018;185:75–81.PubMed

49.

Mahaffey BL, Gonzalez A, Farris SG, Zvolensky MJ, Bromet EJ, Luft BJ, et al. Smoking to regulate negative affect: disentangling the relationship between posttraumatic stress and emotional disorder symptoms, nicotine dependence, and cessation-related problems. Nicotine Tob Res. 2016;18:1471–8.PubMed

50.

Farris SG, Robinson JD, Zvolensky MJ, Hogan J, Rabius V, Cinciripini PM, et al. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addict Behav. 2016;61:32–9.PubMedPubMedCentral

51.

Miele A, Thompson M, Jao NC, Kalhan R, Leone F, Hogarth L, et al. Cancer patients enrolled in a smoking cessation clinical trial: characteristics and correlates of smoking rate and nicotine dependence. J Addict. 2018;2018:1–7. https://doi.org/10.1155/2018/2438161.CrossRef

52.

Lee EM, Malson JL, Waters AJ, Moolchan ET, Pickworth WB. Smoking topography: reliability and validity in dependent smokers. Nicotine Tob Res. 2003;5:673–9.PubMed

53.

• Farris SG, Brown LA, Goodwin RD, Zvolensky MJ. Panic attack history and smoking topography. Drug Alcohol Depend. 2017;171:84–90. This cross-sectional study examined smoking topography among adult daily smokers with and without a history of panic attacks. The results showed that panic attack status was not associated with significant differences in average smoking topography. PubMed

54.

Dahne J, Hise L, Brenner M, Lejuez CW, MacPherson L. An experimental investigation of the functional relationship between social phobia and cigarette smoking. Addict Behav. 2015;43:66–71.PubMed

55.

Watson NL, Heffner JL, McClure JB, Mull KE, Bricker JB. Differential prevalence of established risk factors for poor cessation outcomes among smokers by level of social anxiety. Am J Addict. 2017;26:176–82.PubMedPubMedCentral

56.

Buckner JD, Zvolensky MJ, Lewis EM (2019) Smoking and social anxiety: the role of false safety behaviors. Cogn Behav Ther 0:1–11.

57.

Cloutier R, Blumenthal H, Mischel ER. An examination of social anxiety in marijuana and cigarette use motives among adolescents. Subst Use Misuse. 2016;51:408–18.PubMedPubMedCentral

58.

Lieb R, Miché M, Gloster AT, Beesdo-Baum K, Meyer AH, Wittchen H. Impact of specific phobia on the risk of onset of mental disorders: a 10-year prospective-longitudinal community study of adolescents and young adults. Depress Anxiety. 2016;33:667–75.PubMed

59.

•• Petroulia I, Kyriakos CN, Papadakis S, et al. Patterns of tobacco use, quit attempts, readiness to quit and self-efficacy among smokers with anxiety or depression: findings among six countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2019. https://doi.org/10.18332/tid/98965. This large cross-sectional study was conducted in six European countries and compared smoking behaviors, past quit attempts, readiness to quit, and beliefs about quitting among current cigarette smokers with probable anxiety or depression. It found that smokers with anxiety smoked more cigarettes per day but were equally likely to be daily smokers as those without anxiety or depression.

60.

Nikčević AV, Alma L, Marino C, Kolubinski D, Yılmaz-Samancı AE, Caselli G, et al. Modelling the contribution of negative affect, outcome expectancies and metacognitions to cigarette use and nicotine dependence. Addict Behav. 2017;74:82–9.PubMed

61.

de Matos MB, de Mola CL, Trettim JP, Jansen K, da Silva RA, Souza LDM, et al. Psychoactive substance abuse and dependence and its association with anxiety disorders: a population-based study of young adults in Brazil. Braz J Psychiatry. 2018;40:349–53.PubMedPubMedCentral

62.

• Savage JE, Kaprio J, Korhonen T, Pulkkinen L, Rose RJ, Verhulst B, et al. The effects of social anxiety on alcohol and cigarette use across adolescence: results from a longitudinal twin study in Finland. Psychol Addict Behav. 2016;30:462–74. This longitudinal twin study in Finland examined associations between social anxiety and alcohol/cigarette use and alcohol/nicotine dependence from early adolescence into young adulthood. Results showed that smokers who endorsed a social anxiety screener item were more likely to be daily smokers but showed no association with the same item to nicotine dependence. PubMedPubMedCentral

63.

Zale EL, Maisto SA, Ditre JW. Anxiety and depression in bidirectional relations between pain and smoking: implications for smoking cessation. Behav Modif. 2016;40:7–28.PubMed

64.

Chaiton M, Cohen JE, Rehm J, Abdulle M, O’Loughlin J. Confounders or intermediate variables? Testing mechanisms for the relationship between depression and smoking in a longitudinal cohort study. Addict Behav. 2015;42:154–61.PubMed

65.

Cavazos-Rehg PA, Breslau N, Hatsukami D, Krauss MJ, Spitznagel EL, Grucza RA, et al. Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorder. Psychol Med. 2014;44:2523–35.PubMedPubMedCentral

66.

Richards CS, Cohen LM, Morrell HER, Watson NL, Low BE. Treating depressed and anxious smokers in smoking cessation programs. J Consult Clin Psychol. 2013;81:263–73.PubMed

67.

Zvolensky MJ, Paulus DJ, Langdon KJ, Robles Z, Garey L, Norton PJ, et al. Anxiety sensitivity explains associations between anxious arousal symptoms and smoking abstinence expectancies, perceived barriers to cessation, and problems experienced during past quit attempts among low-income smokers. J Anxiety Disord. 2017;48:70–7.PubMed

68.

Zvolensky MJ, Bakhshaie J, Shepherd JM, Garey L, Viana AG, Peraza N. Anxiety symptoms and smoking among Latinx adult smokers: the importance of sensitivity to internal cues in terms of dependence, barriers for quitting, and quit problems. J Behav Med. 2020;43:88–98.PubMed

69.

Keizer I, Gex-Fabry M, Croquette P, Humair J-P, Khan AN. Tobacco craving and withdrawal symptoms in psychiatric patients during a motivational enhancement intervention based on a 26-hour smoking abstinence period. Tob Prev Cessat. 2019;5. https://doi.org/10.18332/tpc/109785.

70.

Gilbert DG, Rabinovich NE, Gilbert-Matuskowitz EA, Klein KP, Pergadia ML. Smoking abstinence symptoms across 67 days compared with randomized controls—moderation by nicotine replacement therapy, bupropion, and negative-affect traits. Exp Clin Psychopharmacol. 2019;27:536–51.PubMed

71.

Buckner JD, Langdon KJ, Jeffries ER, Zvolensky MJ. Socially anxious smokers experience greater negative affect and withdrawal during self-quit attempts. Addict Behav. 2016;55:46–9.PubMedPubMedCentral

72.

Stark DPH, House A. Anxiety in cancer patients. Br J Cancer. 2000;83:1261–7.PubMedPubMedCentral

73.

Hughes JR, Higgins ST, Hatsukami D. Effects of abstinence from tobacco. In: Kozlowski LT, Annis HM, Cappell HD, Glaser FB, Goodstadt MS, Israel Y, Kalant H, Sellers EM, Vingilis ER, editors. Research advances in alcohol and drug problems, Springer US, vol. 10. MA: Boston; 1990. p. 317–98.

74.

Wiggert N, Wilhelm FH, Nakajima M, al’Absi M (2016) Chronic smoking, trait anxiety, and the physiological response to stress. Subst Use Misuse 51:1619–1628.

75.

Cosci F, Bertoli G, Pistelli F, Carrozzi L, Cosci F, Bertoli G, et al. Depressive, anxious, withdrawal symptoms, and craving as possible predictors of abstinence maintenance in smokers attending a 12-week quitting program. MedicalExpress. 2016;3. https://doi.org/10.5935/MedicalExpress.2016.01.03.

76.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMed

77.

McNair DM, Lorr M, Droppleman LF. POMS manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service; 1971.

78.

Covey LS, Hu M-C, Winhusen T, Lima J, Berlin I, Nunes E. Anxiety and depressed mood decline following smoking abstinence in adult smokers with attention deficit hyperactivity disorder. J Subst Abus Treat. 2015;59:104–8.

79.

Pacheco A, Gómez-Bastero Fernández AP, Valido Morales A, Luque Crespo E, Monserrat S, Montemayor Rubio T. Anxiety, depression and tobacco abstinence. Adicciones. 2017;29:233–44.

80.

Pawlina MMC, Rondina R de C, Espinosa MM, Botelho C, Pawlina MMC, Rondina R de C, Espinosa MM, Botelho C (2015) Depression, anxiety, stress, and motivation over the course of smoking cessation treatment. J Bras Pneumol 41:433–439.

81.

Hammett PJ, Lando HA, Taylor BC, Widome R, Erickson DJ, Joseph AM, et al. The relationship between smoking cessation and binge drinking, depression, and anxiety symptoms among smokers with serious mental illness. Drug Alcohol Depend. 2019;194:128–35.PubMed

82.

Demirezent M, Kurçer MA. Effect of smoking cessation on anxiety and urge for smoking. J Depend. 2017;18:53–8.

83.

Schnoll RA, Hitsman B, Blazekovic S, Veluz-Wilkins A, Wileyto EP, Leone FT, et al. Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes. Drug Alcohol Depend. 2016;165:245–52.PubMedPubMedCentral

84.

Zuo Y, Rabinovich NE, Gilbert DG. Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence. Psychopharmacology. 2017;234:761–71.PubMed

85.

Hughes JR, Stead LF, Lancaster T. Anxiolytics and antidepressants for smoking cessation. Cochrane Database Syst Rev. 2000:CD000031.

86.

Gómez-Coronado N, Walker AJ, Berk M, Dodd S. Current and emerging pharmacotherapies for cessation of tobacco smoking. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2018;38:235–58.

87.

Nagano T, Katsurada M, Yasuda Y, Kobayashi K, Nishimura Y. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials. Ther Adv Respir Dis. 2019;13:175346661987592. https://doi.org/10.1177/1753466619875925.CrossRef

88.

Rigotti NA (2020) Pharmacotherapy for smoking cessation in adults - UpToDate. https://www-uptodate-com.ezproxy.lib.uh.edu/contents/pharmacotherapy-for-smoking-cessation-in-adults/print?search=nortriptyline-drug&source=search_result&selectedTitle=5~90&usage_type=default&display_rank=5.

89.

Bourbon A, Boyer L, Auquier P, Boucekine M, Barrow V, Lançon C, Fond G (2019) Anxiolytic consumption is associated with tobacco smoking and severe nicotine dependence. Results from the national French medical students (BOURBON) study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 94:109645.

90.

Centers for Disease Control and Prevention. Youth and tobacco use. In: Centers for Disease Control and Prevention; 2019. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/youth_data/tobacco_use/index.htm.

91.

Schoenborn CA, Gindi RM (2015) Electronic cigarette use among adults: United States, 2014. National Center for Health Statistics 8.

92.

Chou SP, Saha TD, Zhang H, Ruan WJ, Huang B, Grant BF, et al. Prevalence, correlates, comorbidity and treatment of electronic nicotine delivery system use in the United States. Drug Alcohol Depend. 2017;178:296–301.PubMed

93.

Grant JE, Lust K, Fridberg DJ, King AC, Chamberlain SR. E-cigarette use (Vaping) is associated with illicit drug use, mental health problems, and impulsivity in university students. Ann Clin Psychiatry. 2019;31:27–35.PubMedPubMedCentral

94.

Liu X, Lu W, Liao S, Deng Z, Zhang Z, Liu Y, et al. Efficiency and adverse events of electronic cigarettes. Medicine (Baltimore). 2018;97:e0324. https://doi.org/10.1097/MD.0000000000010324.CrossRef

95.

Hughes JR, Callas PW. Prevalence of withdrawal symptoms from electronic cigarette cessation: a cross-sectional analysis of the US population assessment of tobacco and health. Addict Behav. 2019;91:234–7.PubMed

96.

Mayorga NA, Chavez J, Garey L, Otto MW, Zvolensky MJ (2019) Affective vulnerability across non-daily and daily electronic cigarette users. Behav Med 0:1–9.

97.

Versella MV, Borges AM, Lin C, Leyro TM. Co-use of electronic nicotine delivery systems and combustible cigarettes, and their association with internalizing pathology and vulnerabilities. Cogn Ther Res. 2019;43:114–20.

98.

Garey L, Mayorga NA, Peraza N, Smit T, Nizio P, Otto MW, et al. Distinguishing characteristics of E-cigarette users who attempt and fail to quit: dependence, perceptions, and affective vulnerability. J Stud Alcohol Drugs. 2019;80:134–40.PubMed

99.

Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011;13:401–11.PubMedPubMedCentral

100.

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry. 2005;62:617–27.PubMedPubMedCentral

101.

Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110:585–99.PubMed

102.

Jiang F, Li S, Pan L, Zhang N, Jia C. Association of anxiety disorders with the risk of smoking behaviors: a meta-analysis of prospective observational studies. Drug Alcohol Depend. 2014;145:69–76.PubMed

103.

Zvolensky MJ, Baker K, Yartz AR, Gregor K, Leen-Feldner EW, Feldner MT. Mental health professionals with a specialty in anxiety disorders: knowledge, training, and perceived competence in smoking cessation practices. Cogn Behav Pract. 2005;12:312–8.

104.

Centers for Disease Control and Prevention. Smoking and tobacco use: electronic cigarettes (E-cigarettes). In: Centers for Disease Control and Prevention; 2020. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/about-e-cigarettes.html.

105.

Goodwin RD. Next steps toward understanding the relationship between cigarette smoking and depression/anxiety disorders: a Lifecourse perspective. Nicotine Tob Res. 2017;19:1–2.PubMed

106.

Gage SH, Smith GD, Zammit S, Hickman M, Munafò MR. Using Mendelian randomisation to infer causality in depression and anxiety research. Depress Anxiety. 2014;30:1185–93.

107.

Zvolensky MJ, Bernstein A, Yartz AR, McLeish AC, Feldner MT. Cognitive-behavioral treatment of co-morbid panic psychopathology and tobacco use and dependence. In: Stewart SH, Conrod PJ, editors. Anxiety and substance use disorders: the vicious cycle of comorbidity. Boston, MA: Springer US; 2008. p. 177–200.

108.

Piccirillo ML, Rodebaugh TL. Foundations of idiographic methods in psychology and applications for psychotherapy. Clin Psychol Rev. 2019;71:90–100.PubMed

109.

Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav. 2013;3:302–26.PubMedPubMedCentral

110.

Molas S, DeGroot S, Zhao-Shea R, Tapper AR. Anxiety and nicotine dependence: emerging role of the habenulo-interpeduncular axis. Trends Pharmacol Sci. 2017;38:169–80.PubMed

111.

Fagerström K, Aubin H-J. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin. 2009;25:511–8.PubMed

112.

Bakhshaie J, Zvolensky MJ, Goodwin RD. Cigarette smoking and the onset and persistence of panic attacks during mid-adulthood in the United States: 1994–2005. J Clin Psychiatry. 2016;77:21–4.

113.

Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:566–76.PubMed

Titel: The Role of Anxiety in Smoking Onset, Severity, and Cessation-Related Outcomes: a Review of Recent Literature
verfasst von: Lorra Garey
Hannah Olofsson
Tatyana Garza
Justin M. Shepherd
Tanya Smit
Michael J. Zvolensky
Publikationsdatum: 01.08.2020
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 8/2020
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-020-01160-5

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Role of Anxiety in Smoking Onset, Severity, and Cessation-Related Outcomes: a Review of Recent Literature

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Children’s Reactions to Media Coverage of War

The Psychological Impact of Epidemic and Pandemic Outbreaks on Healthcare Workers: Rapid Review of the Evidence

Children’s Exposure to Single Incidents of Terrorism: Perspectives Over 25 Years Since the Oklahoma City Bombing

Personality Disorders in the ICD-11: Opportunities and Challenges for Advancing the Diagnosis of Personality Pathology

How Personality Disorders Change in Psychotherapy: a Concise Review of Process

Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie